Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Authors
Marcondes C. França (ORCID: https://orcid.org/0000-0003-0898-2419)
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Marcondes C. França, Inmaculada Aban, Ivana Vodopivec, Siân Lennon‐Chrimes et al.
Citations
27 citations
Journal
The Lancet Neurology
Topics
Myasthenia Gravis and Thymoma
Field-Weighted Citation Impact (FWCI)
37.51
article
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Marcondes C. França, Inmaculada Aban, Ivana Vodopivec, Siân Lennon‐Chrimes, Chongbo Zhao, Elzbieta Klimiec, Petranka Krumova, Gerd Meyer zu Hörste, Gil I. Wolfe, Hiroyuki Murai, Gian‐Andrea Thanei, Michael Pulley, Ali A. Habib, Kathleen Blondeau, Darío Tavolini, Jillian Smith, Jorge Gustavo José
article en
27 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet NeurologyVol. 24(2)
Institutions
Roche (Switzerland) (CH), Jagiellonian University (PL), National University of Tucumán (AR), Universidade Estadual de Campinas (UNICAMP) (BR), University of Münster (DE), Fudan University (CN), University of Alabama at Birmingham (US), University of Florida (US), Roche (United Kingdom) (GB), Instituto de Neurología Cognitiva (AR), Centro Científico Tecnológico - Tucumán (AR), Huashan Hospital (CN), University at Buffalo, State University of New York (US), International University of Health and Welfare (JP), Florida College (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial — Marcondes C. França, Inmaculada Aban, et al. · The Lancet Neurology (2025) | TGRS Research Map | TGRS